Carisma Therapeutics Inc. Deferred Revenue (Non-Current)
Carisma Therapeutics Inc. had Deferred Revenue (Non-Current) of $0 as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2025-11-12
- 2025-09-30: Deferred Revenue, Noncurrent $0.00.
- 2025-06-30: Deferred Revenue, Noncurrent $41.25M.
- 2025-03-31: Deferred Revenue, Noncurrent $41.25M.
- 2024-12-31: Deferred Revenue, Noncurrent $41.25M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $41.25M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $41.25M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $41.25M 10-Q · filed 2025-11-12 |
| 2024-09-30 | $41.25M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $41.25M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $45.00M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $45.00M 10-K · filed 2025-03-31 |
| 2023-09-30 | $45.00M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $45.00M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $45.00M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $45.00M 10-K · filed 2024-04-01 |
| 2014-09-30 | $45.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $112.00K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $223.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $355.00K 10-K · filed 2015-03-06 |